Link
COVID-19 vaccine for children 5 to 11 years of age
Organization: Canadian Paediatric Society (CPS)Published: 2021
"On November 19, 2021, the Pfizer-BioNTech COVID-19 vaccine (Comirnaty) was authorized in Canada for use in children 5 to 11 years of age. This document summarizes information specific to this age group." - Canadian Paediatric Society
Resource Group:
Implementation Tool
Product Type: Guide
Vaccine Safety
Sub Topics: Vaccine Safety and Development
Program Planning and Delivery
Program Delivery and Evaluation
Clinics
Specific Populations
Children
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Product Type: Guide
Category:
Vaccine Safety and Development,Vaccine Safety,Sub Topics: Vaccine Safety and Development,Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Specific Populations,Children,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and DevelopmentVaccine Safety
Sub Topics: Vaccine Safety and Development
Program Planning and Delivery
Program Delivery and Evaluation
Clinics
Specific Populations
Children
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Language:
English
AudioResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.